Par Drugs & Chemicals Ltd
company logo

Par Drugs & Chemicals Ltd

PAR Share Price

BSE:535341

NSE:PAR

85.65

1.98 (2.37%)

As on April 6, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

83.67

82.47

3757

0.03

10

Fundamentals

101.48Cr

7.30

0.95

0

11.30

0%

86.50

About

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani. The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business. With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx. 9,700 MTPA. Block 1- APIs, Block 2- Magnesium Hydroxide, Block 3- Fine Chemicals and Block 4- APIs/ Fine Chemicals. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals. The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited. The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019. In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.

1999

PAR

NameDesignation
FALGUN VALLABHBHAI SAVANIChairman / Executive Director / M D / Promoter
JIGNESHBHAI VALLABHBHAI SAVANIExecutive Director & CEO
Krishna Mitulbhai ShahIndependent Non Exe. Director
Kajal Chintanbhai VaghaniIndependent Non Exe. Director
Pravin Manjibhai BhayaniIndependent Non Exe. Director
Bintal Bhaveshkumar ShahIndependent Non Exe. Director
Sanket Bhupendrabhai TrivediCompany Sec. & Compli. Officer

Par Drugs & Chemicals Ltd FAQs

How do I Buy Par Drugs & Chemicals Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Par Drugs & Chemicals Ltd shares in BlinkX.

What is the Share Price of Par Drugs & Chemicals Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Par Drugs & Chemicals Ltd's share price is ₹85.65 as of 2026-04-06.

What is the PE ratio of Par Drugs & Chemicals Ltd?

close

Par Drugs & Chemicals Ltd's P/E ratio is 7.3 times as of 2026-04-06.

What is the PB ratio of Par Drugs & Chemicals Ltd?

close

Par Drugs & Chemicals Ltd's most recent financial reports indicate a price-to-book ratio of 0.95, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Par Drugs & Chemicals Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Par Drugs & Chemicals Ltd's market capitalization is ₹101.48 Cr as on 2026-04-06.

What is the ROE of Par Drugs & Chemicals Ltd?

close

The current financial records of Par Drugs & Chemicals Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Par Drugs & Chemicals Ltd?

close

According to Par Drugs & Chemicals Ltd's most recent financial filings, the company has a total asset value of ₹54.88, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Par Drugs & Chemicals Ltd?

close

The 52-week high/low price of a Par Drugs & Chemicals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Par Drugs & Chemicals Ltd's 52-week high and low as of 2026-04-06 are ₹122.43 and ₹78.05, respectively.